Soluble tumor necrosis factor receptors in chronic hepatitis C:: a correlation with histological fibrosis and activity

被引:161
|
作者
Zylberberg, H
Rimaniol, AC
Pol, S
Masson, A
De Groote, D
Berthelot, P
Bach, JF
Bréchot, C
Zavala, F
机构
[1] Hop Necker Enfants Malad, Hepatol Unit, F-75015 Paris, France
[2] Hop Necker Enfants Malad, INSERM, U25, Paris, France
[3] Hop Necker Enfants Malad, INSERM, U370, Paris, France
[4] Hybridotest Inst Pasteur, Paris, France
[5] Biosource Europe SA, Zoning Ind, Fleurus, Belgium
关键词
hepatitis C virus; liver biopsy; tumor necrosis factor; tumor necrosis factor receptors;
D O I
10.1016/S0168-8278(99)80060-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Tumor necrosis factor-alpha (TNF) is a mediator of inflammation and cellular immune response. Soluble TNF receptors (sTNFR) sTNF-R55 and sTNF-R75, which compete with cellular receptors for the binding of TNF, have been detected at high levels in infectious diseases including human immunodeficiency virus and HBV infection. In order to investigate the activation of the TNF system in HCV infection, we have analyzed the balance between TNF and sTNF-R in 60 HCV-infected subjects according to their clinical, biological, virological and histological characteristics. Methods: Serum TNF, sTNF-R55 and sTNF-R75 levels were determined by ELISA before any therapy and were compared to a control group of 60 healthy subjects and a group of 34 HBV-infected patients. Results: Mean TNF levels were 50.5+/-4.5 pg/ml in HCV patients, and undetectable (<5 pg/ml) in the control subjects. sTNF-R55 and sTNF-R75 levels were significantly higher in HCV-infected patients than in the controls: 2.88+/-0.14 ng/ml vs 1.30+/-0.05, (p=0.0001), and 9.54+/-0.58 ng/ml vs 4.19+/-016, (p=0.0001), respectively, sTNF-R55 and TNF-alpha levels in HCV patients were not significantly different from levels in HBV patients. sTNF-R75 levels were slightly lower than in HBV patients (9.54+/-0.58 vs 11.4+/-0.79 ng/ml, p=0.03). In contrast to other infectious diseases, there was no correlation between levels of sTNF-R and TNF. sTNF-R75 but not TNF levels were correlated with aminotransferases levels (p=0.0001 and p=0.0015 for aspartate and alanine aminotransferase, respectively), while sTNF-R55 levels were significantly correlated only with aspartate aminotransferase levels (p=0.003). sTNF-R75 levels were significantly correlated with the Metavir activity index (p=0.01), and sTNF-R55 and sTNF-R75 levels were significantly higher in patients with vs. without cirrhosis (3.22+/-0.21 vs. 2.54+/-0.17 ng/ml (p<0.02) and 11.6+/-0.86 vs. 7.5+/-0.53 ng/ml (p<0.001), respectively). sTNF-R55, sTNF-R75 and TNF levels were not correlated with viral load, genotype or response to interferon therapy. Conclusions: Levels of soluble TNF receptors, and particularly sTNF-R75, are significantly correlated with the severity of the disease but not with virological parameters such as quantitative viremia and genotype. High TNF-R production could thus suggest that HCV-related liver disease involves immunological mechanisms, including activation of the TNF system.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [1] Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: The differences and implications in pathogenesis
    Tai, DI
    Tsai, SL
    Chen, TC
    Lo, SK
    Chang, YH
    Liaw, YF
    JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (04) : 321 - 327
  • [2] High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders
    Realdon, S
    Pontisso, P
    Adami, F
    Trentin, L
    Noventa, F
    Ferrari, A
    Migliorato, I
    Gatta, A
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2001, 34 (05) : 723 - 729
  • [3] Increased Levels of Soluble Tumor Necrosis Factor Receptors in Atherosclerosis: No Clear Relationship with Levels of Tumor Necrosis Factor
    Andrew D. Blann
    Charles N. McCollum
    Inflammation, 1998, 22 : 483 - 491
  • [4] Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection
    LJ Yee
    J Tang
    J Herrera
    RA Kaslow
    DJ van Leeuwen
    Genes & Immunity, 2000, 1 : 386 - 390
  • [5] Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection
    Yee, LJ
    Tang, J
    Herrera, J
    Kaslow, RA
    van Leeuwen, DJ
    GENES AND IMMUNITY, 2000, 1 (06) : 386 - 390
  • [6] Activation of Tumor Necrosis Factor-α System in Chronic Hepatitis C Virus Infection
    David R. Nelson
    Herbert L. Lim
    Constantine G. Marousis
    Jane W. S. Fang
    Gary L. Davis
    Luping Shen
    Mickey S. Urdea
    Janice A. Kolberg
    Johnson Y. N. Lau
    Digestive Diseases and Sciences, 1997, 42 : 2487 - 2494
  • [7] Tumor necrosis factor-α inhibitors and chronic hepatitis C:A comprehensive literature review
    Maurizio Pompili
    Marco Biolato
    Luca Miele
    Antonio Grieco
    World Journal of Gastroenterology, 2013, (44) : 7867 - 7873
  • [8] Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease
    Janaina Matos Moreira
    Albená Nunes da Silva
    Érica Leandro Marciano Vieira
    Antônio Lúcio Teixeira
    Arthur Melo Kummer
    Ana Cristina Simões e Silva
    Pediatric Nephrology, 2019, 34 : 349 - 352
  • [9] Kinetic Analysis of Interaction between Tumor Necrosis Factor and Soluble Receptors
    Yang Fan
    Yang Xiu-Rong
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2013, 41 (05) : 664 - 669
  • [10] SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CLINICAL LABORATORY DIAGNOSIS
    DIEZRUIZ, A
    TILZ, GP
    ZANGERLE, R
    BAIERBITTERLICH, G
    WACHTER, H
    FUCHS, D
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) : 1 - 8